PagrindinisRKDA • NASDAQ
add
Arcadia Biosciences Inc
Ankstesnė uždarymo kaina
2,30 $
Dienos intervalas
2,21 $ - 2,21 $
Metų intervalas
1,77 $ - 6,71 $
Bendroji vertė rinkoje
4,82 mln. USD
Vidutinė prekybos apimtis
25,48 tūkst.
Kainos ir pajamų santykis
-
Pajamos iš dividendų
-
Pagrindinė akcijų birža
NASDAQ
Rinkos naujienos
Apie
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought. Wikipedia
Įkurta
2002
Pagrindinė būstinė
Svetainė
Darbuotojų skaičius
9